Hundreds of clinical trials are rolled out around the world monthly, and many of them are designed to specifically uncover and manage the medical needs of people with sickle cell disease and trait. We keep an updated list of these global studies here, so you don’t have to go searching for them. There might be active study recruitment and enrollment happening at a site near you. Explore the list below to see the different types of studies, and use the navigation options on the left to get as specific as you would like.
The purpose of this study is to compare the efficacy and safety of 2 doses of crizanlizumab (5.
9 United States sites
9 Brazil sites
6 United Kingdom sites
5 Italy sites
5 Germany sites
5 Belgium sites
4 Spain sites
3 Netherlands sites
3 Colombia sites
3 Greece sites
3 France sites
3 India sites
2 Panama sites
2 Canada sites
2 Lebanon sites
2 Turkey sites
1 South Africa site
1 Kenya site
1 United Arab Emirates site
1 Finland site
1 Ghana site
1 Jordan site
1 Oman site
> 12 Years
Phase 3
This is a single-arm, open-label, multi-site, single-dose Phase 1/2 study in subjects with severe sickle cell disease (SCD).
8 United States sites
1 Belgium site
1 Canada site
1 Germany site
1 Italy site
1 United Kingdom site
12 to 35 Years
Phase 1/Phase 2
The objective of the study is to refine our knowledge on the physiopathology of the symptoms and the complications for the patients affected by a drepanocytic syndrome.
1 Belgium site
> 17 Years
